RxDoctor Payments Data

Anna Reyes-Crawhorn

Psychiatric/Mental Health · Jeffersonville, INNPI 1154978732

Payments from drug & device makers

$2,002in general payments, 2019–2025

Across 95 payments — averaging $21.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$339
  • AbbVie$300
  • Teva Pharmaceuticals USA, Inc.$245
  • Vanda Pharmaceuticals Inc.$159
  • Otsuka America Pharmaceutical, Inc.$138
  • Lundbeck LLC$137
  • plus $684 from 13 others

What the payments were for

  • Food & beverage$1,90395%
  • Education$995%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,002 in reported general payments places this provider in the 70th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$24,735
Medicare patients
123
Services billed
436

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl142$205,869
IngrezzaValbenazine Tosylate24$191,750
Invega SustennaPaliperidone Palmitate34$99,878
RexultiBrexpiprazole40$59,354
AustedoDeutetrabenazine16$58,929
TrintellixVortioxetine Hydrobromide64$37,358
CaplytaLumateperone Tosylate15$25,688
VyvanseLisdexamfetamine Dimesylate34$13,157
Aripiprazole233$11,477
Lurasidone Hcl23$11,344
Asenapine Maleate40$10,624
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine226$6,558
Divalproex Sodium113$6,174
Vilazodone Hcl43$6,090
Paliperidone ErPaliperidone28$6,028

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$300$205,869142 claims
Neurocrine Biosciences, Inc.Ingrezza$79$191,75024 claims
Johnson & JohnsonInvega Sustenna$63$99,87834 claims
Otsuka America Pharmaceutical, Inc.Rexulti$138$59,35440 claims
Teva Pharmaceuticals USA, Inc.Austedo$245$58,92916 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$80$50,51598 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$339$25,68815 claims
Almatica Pharma LLCSertraline Hcl$41$2,414357 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Jeffersonville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →